Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

This study has been completed.

Sponsor:

Information provided by:

Targeted Genetics Corporation

ClinicalTrials.gov Identifier:

NCT00126724

First received: August 2, 2005

Last updated: July 27, 2009

Last verified: July 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2009
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)

No publications provided by Targeted Genetics Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Heald AE, Fudman EJ, Anklesaria P, Mease PJ; 13G01 Study Team. Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examination. J Rheumatol. 2010 May;37(5):1042-8. Epub 2010 Mar 15.

Frank KM, Hogarth DK, Miller JL, Mandal S, Mease PJ, Samulski RJ, Weisgerber GA, Hart J. Investigation of the cause of death in a gene-therapy trial. N Engl J Med. 2009 Jul 9;361(2):161-9.

To Top